These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 25651539)

  • 1. Management of lipid disorders in patients living with HIV.
    Myerson M; Malvestutto C; Aberg JA
    J Clin Pharmacol; 2015 Sep; 55(9):957-74. PubMed ID: 25651539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid management in human immunodeficiency virus.
    Myerson M
    Cardiol Clin; 2015 May; 33(2):277-98. PubMed ID: 25939300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical management considerations for dyslipidemia in HIV-infected individuals.
    Kirchner JT
    Postgrad Med; 2012 Jan; 124(1):31-40. PubMed ID: 22314112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multimodal, evidence-based approach to achieve lipid targets in the treatment of antiretroviral-associated dyslipidemia: case report and review of the literature.
    Bain AM; White EA; Rutherford WS; Rahman AP; Busti AJ
    Pharmacotherapy; 2008 Jul; 28(7):932-8. PubMed ID: 18576908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyslipidemia and lipid management in HIV-infected patients.
    Lo J
    Curr Opin Endocrinol Diabetes Obes; 2011 Apr; 18(2):144-7. PubMed ID: 21297466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenofibrate in the treatment of dyslipidemia associated with HIV infection.
    Samineni D; Fichtenbaum CJ
    Expert Opin Drug Metab Toxicol; 2010 Aug; 6(8):995-1004. PubMed ID: 20604734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation and pharmacologic management of the HIV-infected patient with dyslipidemia.
    Hardwicke RL; Lewis ST; Grimes RM
    J Assoc Nurses AIDS Care; 2010; 21(5):429-38. PubMed ID: 20303794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyslipidemia in HIV patients.
    Tungsiripat M; Aberg JA
    Cleve Clin J Med; 2005 Dec; 72(12):1113-20. PubMed ID: 16392725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk and dyslipidemia among persons living with HIV: a review.
    Maggi P; Di Biagio A; Rusconi S; Cicalini S; D'Abbraccio M; d'Ettorre G; Martinelli C; Nunnari G; Sighinolfi L; Spagnuolo V; Squillace N
    BMC Infect Dis; 2017 Aug; 17(1):551. PubMed ID: 28793863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group.
    Dubé MP; Sprecher D; Henry WK; Aberg JA; Torriani FJ; Hodis HN; Schouten J; Levin J; Myers G; Zackin R; Nevin T; Currier JS;
    Clin Infect Dis; 2000 Nov; 31(5):1216-24. PubMed ID: 11073755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety and effectiveness of statins as treatment for HIV-dyslipidemia: the evidence so far and the future challenges.
    Ahmed MH; Al-Atta A; Hamad MA
    Expert Opin Pharmacother; 2012 Sep; 13(13):1901-9. PubMed ID: 22770622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study.
    Rotger M; Bayard C; Taffé P; Martinez R; Cavassini M; Bernasconi E; Battegay M; Hirschel B; Furrer H; Witteck A; Weber R; Ledergerber B; Telenti A; Tarr PE;
    Circ Cardiovasc Genet; 2009 Dec; 2(6):621-8. PubMed ID: 20031643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyslipidemia in HIV-infected individuals.
    Sprinz E; Lazzaretti RK; Kuhmmer R; Ribeiro JP
    Braz J Infect Dis; 2010; 14(6):575-88. PubMed ID: 21340298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of metabolic complications and cardiovascular risk in HIV-infected patients.
    Blanco F; San Román J; Vispo E; López M; Salto A; Abad V; Soriano V
    AIDS Rev; 2010; 12(4):231-41. PubMed ID: 21179187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyslipidemia related to antiretroviral therapy.
    Estrada V; Portilla J
    AIDS Rev; 2011; 13(1):49-56. PubMed ID: 21412389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral therapy with heart.
    Randell P; Moyle G
    Am J Ther; 2009; 16(6):579-84. PubMed ID: 19940610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid metabolism in treated HIV Infection.
    Dubé MP; Cadden JJ
    Best Pract Res Clin Endocrinol Metab; 2011 Jun; 25(3):429-42. PubMed ID: 21663837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid management in patients who have HIV and are receiving HIV therapy.
    Aberg JA
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):207-22. PubMed ID: 19217520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of statins in the setting of HIV infection.
    Eckard AR; McComsey GA
    Curr HIV/AIDS Rep; 2015 Sep; 12(3):305-12. PubMed ID: 26126687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular implications of HIV-induced dyslipidemia.
    Giannarelli C; Klein RS; Badimon JJ
    Atherosclerosis; 2011 Dec; 219(2):384-9. PubMed ID: 21722900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.